← NewsAll
Max Homa announces health campaign and outlines his 2026 approach
Summary
Max Homa is partnering with Arcutis' Free to Be Me Campaign to raise awareness of seborrheic dermatitis and says he uses ZORYVE (roflumilast) foam; he also discussed enjoying faster formats like TGL while keeping four-day PGA Tour events as his core focus for 2026.
Content
Max Homa announced a new health campaign on February 24 as part of Arcutis' Free to Be Me Campaign and discussed it in an interview with Men's Journal. He described living with seborrheic dermatitis since high school and said he uses ZORYVE (roflumilast) foam under a dermatologist's care. In the interview Homa also spoke about his views on professional golf formats, including TGL and traditional four-day PGA Tour events. He emphasized inclusivity and making the sport easier to consume for younger fans while focusing on steady daily improvement going into the 2026 season.
Key details:
- Homa is a six-time PGA Tour winner and discussed both his health campaign and his playing plans for 2026.
- He announced a partnership with Arcutis' Free to Be Me Campaign, which addresses seborrheic dermatitis.
- Dr. Tina Bhutani, a board-certified dermatologist, said the condition affects more than 10 million Americans and described common symptoms and affected areas.
- Homa said he uses ZORYVE (roflumilast) foam, which he described as a once-daily, light, water-based topical that helped his symptoms.
- On the sport's future, Homa said he enjoys faster formats like TGL for their pace but still considers four-day tournament golf his passion; he also voiced support for making golf more inclusive and easier to consume for younger audiences.
Summary:
Homa announced the Arcutis campaign to raise awareness of seborrheic dermatitis and shared his personal experience using ZORYVE foam, while a dermatologist in the interview noted the condition affects over 10 million Americans. He also discussed balancing interest in faster formats such as TGL with his commitment to four-day PGA Tour events and said his approach for 2026 centers on improving a little each day. Undetermined at this time.
